Despite near unanimous objection from its advisory panel, the U.S. Food and Drug Administration (FDA) granted aducanumab approval to treat Alzheimer's disease on June 7, 2021. In a commentary published in Annals of Internal ...
Jun 18, 2021
0
1
Middle-aged people with depressive symptoms who carry a genetic variation called apolipoprotein (APOE) ε4 may be more at risk to develop tau protein accumulations in the brain's emotion- and memory-controlling regions, a ...
Jun 17, 2021
0
4
A new therapy prompts immune defense cells to swallow misshapen proteins, amyloid beta plaques and tau tangles, whose buildup is known to kill nearby brain cells as part of Alzheimer's disease, a new study shows.
Jun 15, 2021
0
528
Alzheimer's disease is the most common form of dementia and is characterized by neurodegeneration in regions of the brain involved in memory and learning. Amyloid beta and tau are two toxic proteins that build up in disease ...
Jun 14, 2021
0
19
Affecting over 50 million people, Alzheimer's disease is the most common form of dementia and primarily occurs in people over the age of 65. The pathology of the disease in the brain is mainly characterized by two factors: ...
Jun 11, 2021
0
2
Alzheimer's disease is one of medicine's most elusive thieves, a disease that slowly and irreversibly robs a person's ability to think, reason, remember and maintain normal body functioning. The underlying cause of Alzheimer's ...
Jun 10, 2021
1
9
The U.S. Food and Drug Administration has approved the first new drug to treat Alzheimer's disease in nearly two decades, in a controversial decision that left the agency defending its reputation and its science.
Jun 08, 2021
0
0
Latest research from UNSW Sydney's Center for Healthy Brain Aging (CHeBA) has uncovered new insight into the underlying mechanisms of Alzheimer's disease.
Jun 07, 2021
0
10
In a major breakthrough, researchers at Massachusetts General Hospital (MGH) have discovered how amyloid beta—the neurotoxin believed to be at the root of Alzheimer's disease (AD)—forms in axons and related structures ...
May 19, 2021
1
1213
Findings of a study by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest that increasing expression of a gene known as ABCC1 could not only reduce the deposition of a hard plaque ...
Apr 14, 2021
0
11
